Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of stem cells. The company develops stem cell drugs for selected medical applications as well as for research in Germany.
This information is reserved for PitchBook Platform users. To explore RNL Europe‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.